Unapproved Devices

Ophthalmologists are privy to various treatment alternatives, many of which are tested and employed by their peers around the world long before they are approved for use here in the U.S. Before deciding whether or not to use the newest device available, physicians would be well advised to evaluate the patient safety and professional liability risks.

See OMIC’s checklist Risk Analysis of Unapproved Devices below.

Unapproved Devices

See OMIC’s article below.

When FDA Leaves Doctors To Their Own Devices

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.